Skip to search.
 FTSE 100 Up 0.39%

Sarepta Therapeutics, Inc. (SRPT)

-NasdaqGS
24.26 Down 0.08(0.33%) 18:14 - Nasdaq Real Time Price
Prev Close:24.34
Open:24.59
Bid:24.21 x 100
Ask:24.22 x 100
1y Target Est:22.08
Beta:1.42604
Next Earnings Date:N/A
Day's Range:24.11 - 24.83
52wk Range:8.00 - 41.97
Volume:668,479
Avg Vol (3m):6,049,780
Market Cap:1.16b
P/E (ttm):N/A
EPS (ttm):-5.35
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SRPT at this time.

Comparison

Symbol% ChgMkt Cap
SRPTDown 0.33%1.16b
GSKUp 1.63%109.01b
ALNYUp 1.26%5.79b
ISISDown 0.48%6.91b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):889.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-5.12
Quarterly EPS Est (Sep-16) :-1.27
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):23.75

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback